Trials / Completed
CompletedNCT02332044
Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers
A Randomized, Open-label, Single Dose, Three-treatment, Three-period, Six-sequence Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Erdosteine and Bepotastine Besilate After Oral Administration in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the drug-drug interaction between Erdosteine and Bepotastine besilate in healthy adult volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Erdos | capsule, 300mg |
| DRUG | Talion | tablet, 10mg |
| DRUG | Erdos, Talion | capsule 300mg and tablet 10mg |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2014-09-01
- Completion
- 2015-01-01
- First posted
- 2015-01-06
- Last updated
- 2015-01-06
Source: ClinicalTrials.gov record NCT02332044. Inclusion in this directory is not an endorsement.